Literature DB >> 29102801

Depression and sterile inflammation: Essential role of danger associated molecular patterns.

Tina C Franklin1, Chelsea Xu1, Ronald S Duman2.   

Abstract

Stress is a major risk factor for psychiatric disorder including major depressive disorder (MDD) and can induce inflammation, which is known to be dysregulated in depression. Several clinical and pre-clinical studies have demonstrated a strong association between depressive symptoms and the expression of factors that increase inflammation. Conversely, administration of anti-inflammatory agents has been shown to ameliorate depressive symptoms, demonstrating the importance of inflammation as a mediator of depression. Although it is clear that inflammation plays a role in the pathophysiology of depression, the mechanism by which inflammation is activated in mood disorders remains unclear. To address this issue, studies have investigated the role of pattern recognition receptor (PRR) activation in stress-induced inflammation and mood disorders. However, the identification of the endogenous factors, referred to as danger-associated molecular patterns (DAMP) that activate these receptors remains understudied. Here we review the role of DAMPs in depression and highlight the clinical evidence for elevation of DAMP signaling in MDD patients and in pre-clinical animal stress models of depression.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ATP; Cytokines; Depression; HMGB1; HSP70; Inflammation; NLRP3; Psychiatry; RAGE; S100b; Sterile inflammation; Stress; TLR4; Uric acid

Mesh:

Substances:

Year:  2017        PMID: 29102801     DOI: 10.1016/j.bbi.2017.10.025

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  48 in total

Review 1.  The role of Th17 cells in the pathophysiology of pregnancy and perinatal mood and anxiety disorders.

Authors:  Lauren M Osborne; Amitoj Brar; Sabra L Klein
Journal:  Brain Behav Immun       Date:  2018-11-19       Impact factor: 7.217

2.  Tetramethylpyrazine ameliorates depression by inhibiting TLR4-NLRP3 inflammasome signal pathway in mice.

Authors:  Songnian Fu; Jiangtao Wang; Chenguang Hao; Haihong Dang; Sheng Jiang
Journal:  Psychopharmacology (Berl)       Date:  2019-03-07       Impact factor: 4.530

3.  Reversal of a Treatment-Resistant, Depression-Related Brain State with the Kv7 Channel Opener Retigabine.

Authors:  Mengyang Feng; Nicole A Crowley; Akshilkumar Patel; Yao Guo; Sierra E Bugni; Bernhard Luscher
Journal:  Neuroscience       Date:  2019-03-08       Impact factor: 3.590

Review 4.  Subclinical inflammation and depressive symptoms in patients with type 1 and type 2 diabetes.

Authors:  Christian Herder; Norbert Hermanns
Journal:  Semin Immunopathol       Date:  2019-02-18       Impact factor: 9.623

Review 5.  Toll-Like Receptor Signaling in Depression.

Authors:  Leandra K Figueroa-Hall; Martin P Paulus; Jonathan Savitz
Journal:  Psychoneuroendocrinology       Date:  2020-09-01       Impact factor: 4.905

6.  CD300f immunoreceptor is associated with major depressive disorder and decreased microglial metabolic fitness.

Authors:  Natalia Lago; Fernanda N Kaufmann; María Luciana Negro-Demontel; Daniela Alí-Ruiz; Gabriele Ghisleni; Natalia Rego; Andrea Arcas-García; Nathalia Vitureira; Karen Jansen; Luciano M Souza; Ricardo A Silva; Diogo R Lara; Bruno Pannunzio; Juan Andrés Abin-Carriquiry; Jesús Amo-Aparicio; Celia Martin-Otal; Hugo Naya; Dorian B McGavern; Joan Sayós; Rubèn López-Vales; Manuella P Kaster; Hugo Peluffo
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-09       Impact factor: 11.205

Review 7.  Molecular insights into the therapeutic promise of targeting HMGB1 in depression.

Authors:  Tarapati Rana; Tapan Behl; Vineet Mehta; Md Sahab Uddin; Simona Bungau
Journal:  Pharmacol Rep       Date:  2020-10-04       Impact factor: 3.024

8.  Depression as a predictor of postoperative delirium after cardiac surgery: a systematic review and meta-analysis.

Authors:  Anna Falk; Jessica Kåhlin; Carolin Nymark; Rebecka Hultgren; Malin Stenman
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-04-08

9.  Selective serotonin reuptake inhibitor attenuates the hyperresponsiveness of TLR2+ and TLR4+ Th17/Tc17-like cells in multiple sclerosis patients with major depression.

Authors:  Marisa C Sales; Taissa M Kasahara; Priscila M Sacramento; Átila D Rossi; Marcos Octávio S D Cafasso; Hugo A A Oyamada; Joana Hygino; Fabianna Alvim; Regis M Andrade; Cláudia Cristina Vasconcelos; Cleonice A M Bento
Journal:  Immunology       Date:  2020-11-23       Impact factor: 7.397

10.  The impact of mental health on COVID 19 disease progression: Case report.

Authors:  Amine Bouabdallaoui; Salma Taouihar; Ghizlane El Aidouni; Mohamed Aabdi; Rajae Alkouh; Manal Merbouh; Houssam Bkiyar; Bahim Housni
Journal:  Ann Med Surg (Lond)       Date:  2021-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.